Cite
APA Citation
Minari, R., Bonatti, F., Mazzaschi, G., Dodi, A., Facchinetti, F., Gelsomino, F., Cinquegrani, G., Squadrilli, A., Bordi, P., Buti, S., Bersanelli, M., Leonetti, A., Cosenza, A., Ferri, L., Rapacchi, E., Quaini, F., Ardizzoni, A., & Tiseo, M. (2022). pD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Tumori, 108(1), 47–55. http://access.bl.uk/ark:/81055/vdc_100144156294.0x000015